Brink’s Closes $400 Million 5-Year and $400 Million 8-Year Senior Notes Offering
RICHMOND, Va., June 12, 2024 (GLOBE NEWSWIRE) — The Brink’s Company (NYSE:BCO) (the “Company”) today announced that it has closed […]
NANOBIOTIX to Host Virtual KOL Event Discussing Potential of NBTXR3 Combined With Immunotherapy in Head and Neck Cancer and Beyond on June 18, 2024
PARIS and CAMBRIDGE, Mass., June 12, 2024 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a […]
Connect Biopharma Announces New Leadership and Chair of the Board of Directors
Industry leader Barry Quart, Pharm.D. appointed as Chief Executive Officer succeeding Zheng Wei, Ph.D., who will remain on the Board […]
Cerence Appoints Jennifer Salinas, SVP & General Counsel, to New Role of EVP & Chief Administrative Officer
BURLINGTON, Mass., June 12, 2024 (GLOBE NEWSWIRE) — Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, today announced that […]
Greystone Housing Impact Investors LP Announces Regular Quarterly Cash Distribution
OMAHA, Neb., June 12, 2024 (GLOBE NEWSWIRE) — On June 12, 2024, Greystone Housing Impact Investors LP (NYSE: GHI) (the […]
TSX News -
Conifex Announces Secured Term Loan
VANCOUVER, British Columbia, June 12, 2024 (GLOBE NEWSWIRE) — Conifex Timber Inc. (“Conifex”) (TSX: CFF) announced today that it has […]
Oxford: Owner of Tommy Bahama, Lilly Pulitzer and Johnny Was Reports First-Quarter Results
ATLANTA, June 12, 2024 (GLOBE NEWSWIRE) — Oxford Industries, Inc. (NYSE:OXM) today announced financial results for its fiscal 2024 first […]
Ultragenyx Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
NOVATO, Calif., June 12, 2024 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development […]
Noodles & Company Names Scott Davis as Chief Concept Officer
As Former Chief Concept Officer at Panera Bread, Davis led culinary development, category management, restaurant design, and sustainability efforts. At […]
Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., June 12, 2024 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX), today announced that on June […]
